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Abstract 
Background: Hidradenitis Suppurativa is a chronic inflammatory skin disease with a strong 
negative impact on physical and psychological health. Obesity, especially visceral adiposity, but 
also smoking or unhealthy nutritional habits, have been reported to be significantly associated with 
hidradenitis suppurativa.  
Design and Method: Case-control study in 35 patients of both sexes affected with hidradenitis 
suppurativa, and 35 healthy subjects matched for sex, age, and geographic origin (Sardinia, Italy). 
Results: Several anthropometric measures (body mass index, waist circumference, body 
composition), lifestyle (mediterranean diet adherence, and physical activity level), and the 
perceived physical and mental health status were evaluated in case and controls. Hidradenitis 
patients showed significantly higher values of body mass index, waist circumference, body 
composition, fat mass, and lower values of physical and mental health status compared to controls, 
while both groups showed a similar moderate physical activity level which can be assumed to 
counteract the negative effects of obesity or poor nutritional pattern in hidradenitis patients. 
However, none of the evaluated variables were correlated with the severity of the disease, assessed 
by means of the Hurley stage system or the Sartorius score. Instead, the Sartorius score showed a 
positive correlation with the duration of hidradenitis, mainly imputable to the diagnostic delay and 
the consequent long lasting inflammatory status. 
Conclusions: Although nutritional factors and lifestyle can be important and modifiable factors in 
the hidradenitis suppurativa course, the detrimental effect of chronic inflammation and delayed 
management are clearly prevalent and heavily influence the disease burden.  
Key words: Mediterranean diet, lifestyle, physical activity, quality of life, Hidradenitis Suppurativa, 
obesity, inflammation. 
 
Significance for public health  
The negative impact of Hidradenitis Suppurativa on physical and psychological health is 
incontrovertibly high, especially in young adults, in the midst of their social and working life. 
Modifiable negative attitude and lifestyles are an important field of study and intervention, which 
remain controversial. Although smoking and unhealthy nutritional habits, have been reported to be 
significantly associated with Hidradenitis Suppurativa, main studies were performed in 
geographical areas with a high prevalence of obesity. Present case-control study is conducted in a 
sample of Sardinian population, which confirm a lower obesity rate, a certain relevance of altered 
anthropometric measures (body mass index, waist circumference, body composition), lower 
Mediterranean diet adherence, and perceived physical and mental health status in hidradenitis cases. 
However, none of these factors resulted statistically associated with the severity of the disease, as 
opposed to the diagnostic and consequent management delay, which confirms is prominent role on 
the disease burden.  
 
Introduction  
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease also known as acne inversa 
and, historically, Verneuil's disease, that predominantly affects areas of the folds such as the armpits, 
groin, perianal, perineal and inframammary 1,2.  
Clinical manifestations range from the development of recurrent inflammatory painful nodules and  
draining abscesses to the formation of sinus tracts and retracting scars 3. Due to the discomfort 
related to its symptoms and signs, especially pain, pruritus, and suppuration, HS is associated with a 
condition of psychological distress and impaired quality of life 4,5.  
The prevalence of the disease has recently been reported by 0,7-1,2 % in the general European and 
US population, and females are more frequently affected than males 6. Onset generally occurs in 
young adulthood, but a delay in diagnosis and treatment is commonly observed, often related to the 
patient’s reluctance to confide their sufferings to family members themselves, or underestimation of 
the disease progression (Figure 1), limiting the opportunity windows for effective treatment 7, 8.  
In addition to genetic predisposition (it is estimated that 40% of patients have a relative with HS), 
several environmental factors, including adiposity and nutrition, contribute to the clinical severity of 
the HS phenotype 9.  
Obesity is known as a major risk factor for HS. Several studies report a positive association 
between HS severity and body mass index (BMI) 10, 11 and a recent meta-analysis shows that HS 
patients are four times more likely to be obese compared to the general population 12. 
 Overweight or obesity are considered to have a key role in the pathogenesis of HS. In fact, obesity 
induces a low-grade inflammatory state, characterized by high levels of pro-inflammatory cytokines, 
and in particular the macrophages that infiltrate the visceral fat produce pro-inflammatory cytokines 
that exacerbate the activity of HS disease. It has been reported that HS is positively associated with 
waist circumference (WC), which is considered a marker of visceral adiposity and a better predictor 
of cardiovascular and metabolic risk compared to BMI 13.  In addition, the excess of weight could 
favor the onset and worsening of HS due to the excessive friction of the skin on clothes 14. A recent 
characterization of HS phenotypes identifies the axillary‒mammary‒groin phenotype, with 
predominantly anterior body involvement in obese females, as associated with the most severe 
symptoms, and limited response to treatment 15.   
The exacerbating factors of HS also include smoking habits, and nutrition, especially the role of 
dairy products or foods containing brewer's yeast 16, 17, 18. In addition, a suppressive effect of some 
micronutrients as zinc gluconate, vitamin D or riboflavin on skin HS lesions has been observed 19.   
On the other hand, although weight loss after bariatric surgery has been demonstrated to improve 
the severity of HS, it was also described a worsening of the disease probably due to the resulting 
malabsorptive malnutrition 12.   
An Italian study, observed in HS patients compared to a control group, a lower adherence to 
Mediterranean Diet (MD), globally recognised as one of the healthiest nutritional models 20.  
 However, it has been reported that although the nutritional pattern is essential for the maintenance 
of a healthy status and for the prevention of several diseases, other factors, among which a 
sedentary behaviour, are equally important, suggesting to introduce the concept of Mediterranean 
lifestyle instead of that of Mediterranean Diet alone 21.  
On this background, and in order to further elucidate the relationship between Hidradenitis and 
obesity or overweight, we aimed to investigate the anthropometric characteristics, the lifestyle 
habits, in particular the adherence to MD and the physical activity level, and the perception of the 
state of health in a group of patients with Hidradenitis and in a healthy control group, both resident 
in Southern Sardinia, also evaluating whether a diagnostic delay of HS could influence the severity 
of the disease.  
 
Ethic Declaration 
The study was approved by the Local Ethical Committee as part of the activity of a dedicated 
epidemiologic registry (Prot.N.21/11/C.E.) and carried out in accordance with the Code of Ethics of 
the World Medical Association (Declaration of Helsinki) for experiments involving humans. 
Written informed consent was signed by the patients or by their parents for subjects younger than 
18 years. 
 
Design and Methods 
A sample of 35 Sardinian patients of both sexes affected with HS attending the outpatients 
Dermatology Unit of the University Hospital of Cagliari were involved in the study, and referred to 
the Obesity Unit of the same University Hospital from March 2019 to November 2020.  
A control group of 35 healthy Sardinian subjects, matched by sex and age, was recruited among 
hospital volunteers and students. 
None of the patients or controls, had followed any specific nutritional program or hypocaloric diet 
for at least one year. None of the women enrolled in the study reported to be pregnant or 
breastfeeding. 
The collected information included demographic and clinical data, anthropometric measures, 
lifestyle habits, and the health status assessment. In particular, each patient underwent a full clinical 
evaluation including family and personal medical history, information about smoking, alcohol 
habits, and drug intake, physical examination and measurement of vital signs. In addition, a blood 
test comprising routine haemato-chemistry, fasting glucose, and lipide profile was performed.  
 Regarding HS, the age at onset and the age of first diagnosis were investigated by the dermatologist, 
who also assessed the severity of the disease by means of the very simple, descriptive Hurley Stage 
System 22, and the Sartorius Score, which is a more complex but objective method to quantify the 
severity of HS, allowing a scale of numerical scores 23.  The Hurley stage system describes three 
distinct clinical stages, in particular, stage I: single or multiple abscesses, without sinus tracts and 
scarring; stage II: recurrent, single or multiple abscesses widely separated from normal skin, with 
initial sinus tract and scars formation; Stage III: diffuse or near-diffuse involvement, or multiple 
interconnected tracts and abscesses across the entire area.  The Sartorius assessment is based on the 
following criteria: i) the anatomic region involved: 3 points for each region; ii) the number and type 
of lesions: 2 points for each nodule, 4 points for each fistula, 1 point for each scar, 1 point each for 
‘other’; (ii) the longest distance between two relevant lesions in each region: 2 points for less than 5 
cm, 4 points for less than 10 cm, 8 points for more than 10 cm; or lesion size if only one lesion is 
present: 2 points for less than 5 cm, 4 points for less than 10 cm, 8 points for more than 10 cm; (iiii) 
lesions clearly separated by normal skin in each region: 0 points for ‘yes’, 6 points for ‘no’. The 
total score is obtained through the sum of the regional scores with an open upper limit.  
The anthropometric assessment consisting in the measurement of height and body weight, the 
calculation of the relative BMI, the measurement of the waist circumference (WC) and the 
impedance analysis of body composition (BIA) was performed by the same nutritionist as follows: 
the body weight expressed in kg was measured with an impedance scale (TANITA BC 420), also 
used for the body composition analysis (fat mass, FM, fat free mass FFM, muscle mass, MM), 
while the height expressed in cm was measured with a wall statimeter (SECA) consisting of a 
vertical bar incorporating the meter and a horizontal one to put in contact with the highest point of 
the head; the BMI was calculated through the ratio between the weight in kg and the height in m2, 
and used to  classify the weight status of the subjects; the WC, expressed in cm, was measured with 
an anaelastic flexible meter on the upper edge of the iliac crests considering the cut-offs of the IDF 
criteria, 80 cm for females and 94 for males 24.  
The lifestyle evaluation was performed by means of validated and standardized questionnaires, 
administered by the same qualified operators (nutritionist and endocrinologist) during an interview, 
and included the assessment of the adherence to the Mediterranean diet with the MedDietScore 25, 
the ascertainment of the physical activity level with the IPAQ questionnaire 26, and the assessment 
of the state of health, with the SF-12 questionnaire both in patients and controls 27.  
The Med Diet Score, considers 11 food groups, and assigns an increasing score from 0 to 5, on the 
basis of the monthly consumption of foods considered to be close to the Mediterranean pattern, and 
a decreasing score from 5 to 0, on the basis of the monthly consumption of foods considered away 
from the same model; the total score, obtained with the sum of the 11 individual scores (one for 
each food group), ranges from 0 to 55, and higher values indicate a higher adherence to MD.   
The IPAQ questionnaire, used in its short form, allows to assess the physical activity level, 
according to the estimated energy expenditure derived from the reported physical activity (vigorous, 
moderate and walking) and expressed in Metabolic Equivalent of Task-minutes per week (METs/w). 
IPAQ allows also to estimate the sedentary behavior, assessing the mean daily sitting time (h/day). 
The SF-12 questionnaire (short form survey), the shortened version of the original SF-36 
questionnaire, measures both physical (PCS) and mental component (MCS) of the health status; 
each score ranges between 0 and 100, with a higher score indicating better health.  
 
Statistical analysis 
The normality of continuous data was evaluated with the Shapiro-Wilk test. Continuous variables 
are presented as mean value ± standard deviation (M±SD) or median (range), based on the 
distribution of the data. Categorical variables are expressed as absolute number and percentage.  
A t-test for independent samples was performed to compare the mean scores of anthropometrical 
measurements and lifestyle factors of patients and controls. Differences in the frequency of sex and 
smoking status between the two groups were evaluated by Pearson’s chi-squared test. Correlation 
between Sartorius score and patient characteristics was detected by Spearman’s correlation. 
Differences in the Sartorius score between male and female patients were evaluated by the Mann-
Whitney U test, while the comparison of patient characteristics between the two sexes was 
performed by t-test for independent samples. Differences in clinical data in the three Hurley staging 
(from 1 to 3) of patients, were compared by one-way ANOVA for independent samples. A post hoc 
analysis was conducted only if the omnibus test was statistically significant.  
A p-value <0.05 was considered statistically significant for all the analyses performed. 
All analyses were conducted using the SPSS statistical package (version 23 for Windows. SPSS, 
Inc. Chicago, IL, USA). 
 
Results 
The study sample consisted of 35 HS patients (22 females and 13 males) with an average age of 
30.11 +/- 10 years and 35 healthy subjects, matched by sex and age, as control group.  No statistical 
differences between males and females in terms of age were observed both in patients and controls. 
The average age of onset of the disease turned out to be 19.5 +/- 11.9 years in the whole sample, but 
males showed an earlier onset compared to females (15.6 +/- 8.3 vs 21 +/- 13 years; p=0.014).  The 
average age of diagnosis was 27 +/- 10.3 years in the total sample, earlier in males than in females 
(23 vs 30; p= 0.014). The mean interval time between onset and diagnosis was in the total sample 8 
+/- 8.7 years, without any difference between the two sexes (p=0.612). Consequently, also the 
duration of HS (10.7 +/- 7.9 years in the total sample) was similar in both sexes (p=0.780) 
The clinical evaluation showed that the localizations of the HS lesions were distributed as follows: 
genital and inguinal region (88.6%), armpits (62.9 %), buttocks (40%), mammary region (25.7%), 
trunk (6%).  
The severity of the disease, calculated by means of the Sartorius score, revealed, in the whole 
sample, a median value of 63 (range 23-101), without any significant difference between males 
(median value = 64; range 26-100) and females (median value = 78; range 25-101) when compared 
by Mann-Whitney test (p=0.602).  
The Hurley Stage System, showed that 8 patients (22,8%) presented with stage 1, 16 patients 
(45,7%) with stage 2 and 11 patients (31,4%) with stage 3. The percentage of patients diagnosed 
with stage 3 was higher in males than in females (38.5% vs 27.3%); however, no significant 
differences were found in terms of frequency of the different stages between the two groups. 
The medical history allowed us to detect that, 20 patients (57,1%; 9 M, 11 F) were smokers (at least 
one cigarette per day) and 15 patients (42,9%; 4 M,11 F) were non-smokers (p=0.267); with regard 
to alcohol consumption, this habit was declared by 16 patients (45,7%; 6 M, 9 F), while 19 patients 
declared to be abstainers (54,3%; 14 F, 5 M). Concerning both these habits, no significant 
differences were observed between the two sexes (Table 1). 
Regarding clinical data, the mean systolic and diastolic blood pressure values were of 116 +/- 19 
mmHg and 68 +/- 12 mmHg respectively, the mean glycaemic values were 91.4 +/- 13.5 mg / dl, 
the mean triglyceridemia was 95 +/- 35.4 mg / dl, the mean cholesterol value was 200 +/- 51 mg / dl, 
while the HDL cholesterol value was 55.7 +/- 13.5 mg / dl, without any difference between the two 
sexes. Based on IDF diagnostic criteria, metabolic syndrome was present in 5 female patients. 
The results of the anthropometric evaluation in HS patients are shown in table 2: the mean body 
weight was 74.08 +/- 15.7 kg (M: 77 +/- 14 kg; F: 72.15 +/- 16.67 kg) and the mean BMI value of 
27.3 +/- 6.35 kg / m2 (M: 25.5 +/- 5.55 kg / m2; F: 28.3 +/- 6.8 kg / m2). No statistically significant 
differences were observed between the two sexes (p=0.295).  
According to BMI values, 16 patients (45%; 7 males and 9 females), were classified as normal 
weight, 8 patients (22.9%; 4 males and 4 females) as overweight and 11 patients (31.4%; 2 males 
and 9 females) as obese. Overall, 19 patients (54,3%) had an excess of weight. 
The mean WC value was 89.32 +/- 14.8 cm in the total sample, 87.3 +/- 14.3 cm in males and 90.04 
+/- 14.8 cm in females; the average value was higher than the specific sex reference limit (80 cm) 
exclusively in the female sex. 
Regarding the body composition, evaluated with the bio-impedance analysis, the mean values of fat 
mass (FM), fat free mass (FFM) and muscle mass (MM) as well as the mean value of basal 
metabolic rate (BMR) are reported in Table 2, that shows in male patients a significant higher FFM 
and MM than in females. 
The lifestyle evaluation, consisting of the nutritional analysis and the assessment of the physical 
activity level by means of the specific questionnaires MDS and IPAQ, showed an average MDS of 
26.8 ± 6.4 in the whole sample, with very similar scores in the two sexes (M: 27, 1 ± 7.9; F: 26.6 ± 
5.4), while the IPAQ questionnaire, revealed a mean energy expenditure of 1610 ± 1548 METs / 
week, with a statistically significant difference between the two sexes (M: 2621 ± 247; F: 1012 ± 
693; p = 0.002); regarding the mean daily sitting time, of 6.7 ± 3.3 hours in the total sample, no 
significant differences were observed between the two sexes (M: 6.5 ± 3.9; F: 6.88 ± 2.9). Finally, 
the SF12 questionnaire showed similar mean values of the two synthetic indexes, PCS and MCS, in 
the whole sample (46+/- 10 and 48 +/- 11 respectively), without any statistically significant 
difference between males and females. Lifestyle and SF-12 data are reported in Table 2. 
By comparing the group of HS patients with the control group (Table 3), the presence of significant 
differences in the mean values of BMI, WC, FM, all higher in HS patients than in controls, and in 
the mean values of MDS and SF-12 PCS, both lower in HS patients than in controls, was observed, 
as shown in Table 2, whereas there were no significant differences between the 2 groups regarding 
FFM, physical activity level and SF-12 MCS. Concerning SF-12 MCS, a lower, although not 
significant value was observed among overweight or obese HS patients compared to normal weight 
ones. The prevalence of overweight and obesity was significantly higher in HS patients than in 
controls (p= 0.02), among whom, 26 subjects (74,3%) had a normal weight, 9 subjects (25,7%) had 
a slight overweight, and none of them had an obesity. Moreover, among HS patients there was a 
significantly higher prevalence of smokers (p=4 x 10-7) than in controls, while, the alcohol 
consumption, was similar between the two groups.  
On the basis of these results, we investigated the presence of a possible association between the 
anthropometric characteristics, the lifestyle variables, the heathy status indexes, and the severity of 
HS, evaluated by means of the Hurley stage system or the Sartorius score. Although clinical 
impressive differences among patients with increasing BMI index and worsening disease severity 
index (Figure 2), when we divided the HS patients into three groups, according to the Hurley stages, 
we didn’t find any association between the different stages and each of the considered variables. A 
similar not significant result was observed when we evaluated the Sartorius Score in the HS patients, 
grouped according to BMI classes, as well as when we analysed the correlation between the 
different variables and the Sartorius Score.  
On the other hand, the Sartorius Score was significantly correlated with the duration of HS 
(Spearman test: p=0.016, R= 0.406), as showed in Figure 3.  
 
Discussion 
In our study, patients affected by HS, show significantly higher BMI, WC, and FM values, and a 
higher prevalence of overweight and obesity, than healthy control subjects matched for sex and age, 
and coming from the same geographical area (Sardinia, Italy). This finding agrees with the literature 
data, that highlight the key role of the adipose excess, and especially visceral obesity, in the 
pathogenesis of HS, despite the variable prevalence of overweight and obesity reported in different 
studies among HS patients 28.  
In this regard, our results differ from those of two other Italian studies, that reported, in HS patients 
coming from Campania, a higher prevalence of overweight and obesity, and higher values of the 
anthropometric indexes than those observed in our patients 20, 29.  probably reflecting the different 
prevalence of obesity in the general population of the different Italian regions. In fact, Sardinia has 
one of the lowest prevalence, and Campania one of the highest, especially among children and 
adolescents 30.  Moreover, in one of the Italian studies aforementioned, the control group also had a 
high prevalence of obesity. Nevertheless, in the same study, the BIA analysis, showed that HS 
patients, despite a BMI similar to that of control subjects, presented several alterations in body 
composition not observed in controls, but associated to the severity of HS, and suggestive for an 
inflammatory state 20. 
Chronic inflammation represents the central component in the pathophysiology of the skin lesions 
of HS. The natural characteristics of the skin areas involved, the high temperature and moisture, the 
reduced oxygen availability, and the specific microbiome composition, favor the development of 
the inflammatory process that starts in the perifollicular area, and subsequently determines the 
occlusion and dilatation of the hair follicle unit. The resulting bacterial growth with the particular 
increase of the anaerobic taxa, and the release of damage-associated molecules, induce the 
activation of local macrophages, the secretion of pro-inflammatory cytokines, and the infiltration of 
immune cells, especially neutrophilic granulocytes, worsening the inflammation process, and finally 
leading to the destruction of the hair follicle unit 31.  
Obesity, body composition alterations, and particularly visceral adiposity, are also characterized by 
a low-grade chronic inflammation, with the production of pro- inflammatory cytokines such as IL-
1β and TNF-α, and are considered major contributors to the development of HS 32. Central obesity 
and metabolic syndrome have been reported in a large proportion of HS patients, even before the 
diagnosis of HS 33. 
 Among the environmental factors involved in the pathogenesis of obesity and its complications, 
lifestyle is fundamental, and several studies investigated its role in HS patients. 
 In particular, it have been highlighted the role of tobacco smoking and the effect of nicotine on the 
skin 34, and a high prevalence of smokers has been found among HS patients 35, 36. 
Another field of interest, is represented by the evaluation of the dietary patterns in HS patients, and 
a negative role of some components of diet, such as dairy food 37 or brewer’s yeast 38 has been 
hypothesized.  In the study of Fernandez et al., a sample of HS patients was asked, by means of an 
anonymous questionnaire, to indicate foods that respectively exacerbated or alleviated HS 
symptoms; among the former, were indicated sweets, carbohydrates, dairy and high-fat foods, while 
among the latter, were indicated vegetables and fruits, chicken and fish 39.  
Mediterranean Diet, characterized by a high intake of vegetables, fruit, legumes, wholegrains and 
fish, and by a low intake of meat and dairy, is considered one of the healthiest nutritional models, 
and due to its richness in antioxidants compounds, such as polyphenols, contained in plant-derived 
food, it has considered to have a protective role against both inflammation and obesity, as well as to 
modulate the gut microbiota composition in obese patients 40, 41,42.   
In HS patients, a low adherence to the Mediterranean Diet has been observed, and in detail, a 
nutritional pattern characterized by an excess of simple carbohydrates and saturated fats, and a low 
intake of complex carbohydrates, fiber, mono-unsaturated and n-3 poly-unsaturated fats has been 
described. Moreover, in the same study, the degree of adherence to Mediterranean Diet, has been 
shown to be negatively associated to the severity of HS 20.  
In line with the literature, we found a significantly higher proportion of smokers among HS patients, 
compared to healthy subjects. Moreover, HS patients showed a significantly lower adherence to the 
Mediterranean Diet than that of controls. Altogether, these results are indicative of an unhealthy 
lifestyle. 
In addition to eating habits and nutritional patterns, the other fundamental aspect of lifestyle is 
physical activity. The negative impact of the sedentary behaviour on general health 43, and the 
crucial role of physical activity in the prevention and treatment of obesity and non-communicable 
diseases 44, 45 have been well established. However, there is no data about this aspect in HS patients. 
An accurate estimate of energy expenditure requires a complex, and also expensive evaluation 46. 
The short form of IPAQ is a simple, but reliable and valid tool for assessing and monitoring the 
physical activity level 26. We assessed, by means of IPAQ, the physical activity level in our study 
population, obtaining similar results in HS patients and in controls. In contrast to dietary habits, 
significantly worse in patients than in controls, both groups showed a moderate physical activity 
level and a comparable daily sitting time.  
 We therefore investigated the possible association between the anthropometric indexes or the 
lifestyle aspects and the severity of HS, evaluated both with the Hurley Stage System and the 
Sartorius Score, but we did not find any significant result.  
This finding is in contrast with other studies, that reported an association between BMI values 47, 48, 
BIA alterations or Mediterranean Diet adherence 20, and the Sartorius score. 
A possible explanation is that in our HS patients, the moderate physical activity level, similar to that 
observed in healthy controls, could exert a protective effect on health, counteracting the negative 
impact of the other factors, and particularly the poor eating habits. In fact, it has been demonstrated, 
that regular physical activity may help in maintaining or losing weight, as well as in improving the 
metabolic alterations associated to overweight or obesity, such as insulin resistance, lipid disorders 
and hypertension. In addition, aerobic exercise has shown to reduce inflammation 49.  
Our HS patients’ group, although having higher BMI and WC values than the control group, 
showed, a mean WC value not particularly high. Moreover, considering the two sexes separately, 
we observed that the WC mean value, exceeded the cut-off value exclusively in females, who had a 
physical activity level significantly lower than males. In addition, male patients showed a better 
body composition than females, with lower, although not significant, BMI and FM values, and 
significantly higher FFM and MM values, all attributable to a more active lifestyle.  
Furthermore, the few patients who showed clinical data compatible with the diagnosis of metabolic 
syndrome, were all females.  
Finally, despite the not significant result, in our patients, even the Sartorius score showed a lower 
trend in males than in females.  
Unlike the results obtained with the other variables, we found a significant correlation, between the 
Sartorius Score and the duration of HS. Considering that the duration of HS comprises also the 
period preceding the diagnosis of the disease, we hypothesized that the diagnostic delay has had a 
strong impact on the clinical severity of HS. An average diagnostic delay of more than seven years 
has been reported worldwide 50 and our results are in line with this data. Moreover, our results also 
agree with those obtained by Kokolakis et al., who in a cohort of German HS patients, reported an 
association between the diagnostic delay and the severity of HS, by means of the Hurley Stages 
system. In that study, an increased number of comorbidities linked to the inflammatory status, and 
an impairment of the patient’s professional life were also associated to the diagnostic delay 51. A 
similar result was found by Omine et al., in Japanese HS patients, in whom the severity of the 
disease evaluated with the Sartorius Score, correlated with the duration of the disease 52. 
Interestingly, as in our study, the researchers did not find any association between the Sartorius 
score and the BMI value, which indeed, showed, in Japanese patients, a mean value similar to that 
observed in our patients.  
Furthermore, we evaluated the perceived state of health, by means of the SF-12 questionnaire, 
obtaining in HS patients, compared to controls, a significantly lower physical score, but a 
superimposable mental score. It has been reported that HS, due to its disabling clinical features, has 
a strongly negative impact on health and quality of life 53, and in a recent study performed on an 
Italian HS cohort compared to a representative sample of the Italian general population, it has been 
observed a worse score of both physical and mental health status evaluated with the SF-36 (in 
patients) or the SF-12 (in controls) questionnaire. In particular, the authors reported that young HS 
patients, even if affected by a mild or moderate form of the disease, showed scores similar to those 
of older controls 54. Moreover, the same group of researchers, reported that the level of pain was 
associated with the clinical severity of HS 55.  This finding is partially in contrast with our results, 
that did not show, a significant association between the physical score, that includes the perception 
of pain, and the Hurley or the Sartorius scores. Hidradenitis has been also associated to a poor 
mental health, with a high frequency of anxiety and depression, and a negative impact on quality of 
life 56. In our study, we obtained in HS patients a mental score not significantly different than that 
observed in the control group, with a mean value only slightly lower in HS patients classified as 
Hurley stages 2 or 3 compared to those classified as stage 1. In this regard, our results agree in part 
with those of the group of Sampogna et al., who showed that the severity of HS was not associated 
to depression, despite an important frequency of depression among HS patients 57.  Finally, a 
slightly, but not significantly lower MCS mean value, was found in HS overweight or obese 
patients compared to normal weight HS patients, probably due to the involvement of 
psychopathological factors in obesity 58,59.   
This study has some limitations. First of all, the small number of HS patients, that could have 
limited the power of the statistical analysis. Unfortunately, the recruitment phase fell into the 
prolonged lockdown period consequent to the COVID-19 pandemic in Italy, and the general 
measures to limit the access to the hospitals for not urgent cares. Controls were recruited among 
volunteers and students, to be matched with patients’ demographics. Another limitation is in the 
cross-sectional, non-interventional design of the study, which did not allow the evaluation of the 
potential effects on the severity of HS, of some modifiable lifestyle factors, such as the adherence to 
the Mediterranean Diet, that might be modified through the adoption of an appropriate nutritional 
program. In addition, the BIA analysis, performed with a BIA scale, did not allow to determine 
some variables of the body composition, such as the phase angle, that in previous studies resulted to 
be altered in HS patients. Finally, the study population included both naïve and treated patients, and 
because of the different therapeutic approaches, the possible impact of the specific treatment on the 
severity of the disease was not evaluated. 
 
Conclusions  
In line with other studies, our HS patients show a higher prevalence of overweight and obesity in 
respect to healthy controls, both of Sardinian origin, despite an overall prevalence of obesity lower 
than esteems reported from other Italian regions. Moreover, among HS patients, compared to 
controls, we found a higher proportion of smokers, worse eating habits and an impaired perceived 
physical health status, highlighting the importance of the systematic evaluation of the many factors 
behind body mass index. Surprisingly, we found no statistically significant association between all 
these altered lifestyle components and the severity of the disease. A possible explanation is that 
maintained levels of physical activity, which in our HS patients did not differ from controls, might 
exert a positive, protective effect against the other unhealthy lifestyle factors. Instead, the finding of 
a significant association between the Sartorius score and the disease duration confirms the negative 
prognostic influence of the diagnostic delay, and the detrimental effect of the chronic inflammation.  
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Table 1. Demographic and clinical data in the whole HS sample and by sex. 
Variable Whole sample Males Females p-value 
HS patients (%) 35 13 (37.1) 22 (62.9) 0.055 
Age (yrs) 30.1 +/- 10  25.7 +/- 7.4 32.7 +/- 10.8 0.056 
Onset HS (yrs) 19.5 +/- 11.9 15.6 +/- 8.3 21 +/- 13 0.014 
Diagnosis HS 
(yrs) 
27 +/- 10.3 23 +/- 6.7  30+/- 11.2 0.014 
Interval time 
(yrs) 
8 +/- 8.7 7.4+/-7.5 9+/-10 0.612 
Duration HS (yrs) 10.6 +/- 7.9 10.1+/- 7.5 10.9+/-8.3 0.780 
Sartorius Score 63 (23-101) 64 (26-100) 78 (25-101) 0.602 
Hurley stage 1 
(%) 
8 (22.8) 3 (23.1) 5 (22.7) 1.000 
Hurley stage 2 
(%) 
16 (45.7) 6 (46.2) 10 (45.5) 1.000 
Hurley Stage 3 11 (31.4) 5 (38.5) 6 (27.3) 0.707 
Smoking habit 
(%) 
20 (57.1) 9 (69) 11 (50) 0.312 
Alcohol habit (%) 15 (42.8) 6 (46.1) 9 (40.9) 1.000 
     
 
Table 2. Anthropometric, lifestyle, and status of health data in the whole HS sample and by sex. 
 
Variable (M±DS) Whole sample Males Females p-value 
Weight (kg) 74.08 ± 15.7 77 ± 14 72.15 ± 16.7 0.211 
BMI (kg/m2) 27.3 ± 6.35 25.5 ± 5.55 28.3 ± 6.8 0.295 
WC (cm) 89.3 ± 14.8 87.3 ± 14.3 90.0 ± 14.8 0.378 
FM (kg) 20.8 ± 11.8 14.55 ± 10.2 24.4 ± 10.8 0.312 
FFM (kg) 52.1 ± 9.7 62.1 ± 6.4 45.4 ± 4.1 0.025 
MM (kg) 49.5 ± 9.3 59.0 ± 6.1 43.1 ± 3.9 0.024 
BMR (kcal) 1596 ± 266 1841 ± 201 1441 ± 168 0.147 
MDS 26.8 ± 6.4 27.1 ± 7.9 26.6 ± 5.1 0.085 
IPAQ 
(METs/week) 
1610 ± 1548 2621 ± 247 1012 ± 693 0.002 
Sitting time (h/die) 6.7 ± 3.3 6.5 ± 3.9 6.9 ± 2.9 0.522 
SF-12 PCS 46 ± 10 46 ± 12  47 ± 8 0,841 
SF-12 MCS 48 ± 11 50 ± 12 46 ± 11 0.441 
 
Table 3. Anthropometric, lifestyle and state of health variables in HS patients and controls.  
Variable HS patients Controls p-value 
BMI (kg/m2) 27.3±6.3 23.1 ± 2.8 0.001 
WC (cm) 89 ± 14 82 ± 9 0.019 
FM (kg) 21 ± 12 14 ± 6 0.002 
FFM (kg) 52 ± 10 50 ± 10 0.447 
MDS 26 ± 6 31 ± 7 0.007 
IPAQ (METs/week) 1610 ± 1548 1212 ± 807 0.177 
SF-12 PCS 46 ± 10 54 ± 5 1.5 x 10-4 
SF-12 MCS 48 ± 11 48 ± 10 0.960 
 
 
Figure 1. (A) 16 years old boy with initial HS lesions, Hurley stage 1, on the right armpit, who for 
personal reasons returns to visit 3 years later, with Hurley stage 3 lesion (B). 
 
 
Figure 2. Increasing BMI and HS severity staging in 3 different male patients, with lesions on the 














Figure 3. Spearman Correlation between Sartorius score and duration of HS. 
 
 
 
 
